Clinical Trials
96 trialsRELEVENT
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
DART
University Hospital, Ghent
HOLIPANC
University of Cologne
Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma
Jiangsu Cancer Institute & Hospital
V-CHANCE
National Cancer Institute, Naples
PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II Trial
Sichuan Cancer Hospital and Research Institute
BRISK
Asan Medical Center
The Efficacy and Safety of Penpulimab in the Treatment of Metastatic PPGL Patients Who Fail to Other Systemic Treatment
Peking Union Medical College Hospital
Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC
OncoSec Medical Incorporated
COLT
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma
California Pacific Medical Center Research Institute
FOOTPATH
Ludwig-Maximilians - University of Munich
PRaG Regimens Rechallenge for Patients With Resistance to PD1/PD-L1 Inhibitors in Refractory Advanced Solid Tumors.
Second Affiliated Hospital of Soochow University
MULAN
Fudan University
A Clinical Study of the Efficacy and Safety of Chidamide in Combination With Camrelizumab and Carboplatin or Capecitabine in the Second and Third Line Treatment of Relapsed/Metastatic Triple-negative Breast Cancer
Fudan University
Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer.
Portland VA Medical Center
TONIC
The Netherlands Cancer Institute
EPIC-1
Aalborg University Hospital
WUHIPEC01
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
X7-7
University of Kansas Medical Center
SURF
Centre Hospitalier Universitaire de Besancon
LM-HNSCC
ChineseAMS
TITAN-TCC
AIO-Studien-gGmbH
Apatinib Monotherapy Versus Apatinib Combined With Camrelizumab for Third-line Treatment of Metastatic Gastric Cancer
Fudan University
AVATAR
Hospital Universitario de Fuenlabrada
A Phase II Study of Nivolumab in Patients With Genetic Alterations in DNA Damage Repair and Response Who Progressed After Standard Treatment for Metastatic Solid Cancers
Korean Cancer Study Group
TIDE-A
Consorzio Oncotech
Safety and Efficacy of Recombinant Humanized Anti-PD-1 mAb for Patients With Locally Advanced or Metastatic Melanoma
Shanghai Junshi Bioscience Co., Ltd.
Safety and Efficacy of Toripalimab for Patients With Locally Advanced or Metastatic Bladder Urothelial Carcinoma
Shanghai Junshi Bioscience Co., Ltd.
Oligo-metastases NPC Patients Received Radiation for Primary Tumors and Treatments for Metastatic Lesions
Zhejiang Cancer Hospital
BATTLE
Sixth Affiliated Hospital, Sun Yat-sen University
REACHIN
Erasme University Hospital
Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma
West China Hospital
Pemetrexed Disodium in Treating Patients With Recurrent Malignant Gliomas, Primary CNS Lymphoma, or Brain Metastases
Northwestern University
FLIPPER
Spanish Breast Cancer Research Group
Apatinib in the Treatment of Recurrence or Metastasis of Esophageal Cancer
Shanghai Chest Hospital
Short Course Radiotherapy, Unresectable Rectal Cancer, Liver Metastasis
Yonsei University
APT-01
Nanjing First Hospital, Nanjing Medical University
SuAx
Instituto do Cancer do Estado de São Paulo
sbrtlungfff
Institut Català d'Oncologia
NICE-COMBO
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
MICADO
International Group of Endovascular Oncology
Clinical Studies by Using Alphacait to Screen Drugs for Advanced Solid Tumor
Haining Health-Coming Biotech Co., Ltd.
Hormone Therapy With or Without Definitive Radiotherapy in Metastatic Prostate Cancer
University Hospital Sestre Milosrdnice
DOSE
Dong-A University Hospital
HERZUMA-GC
Dong-A University Hospital
PALPETBIO
Assistance Publique - Hôpitaux de Paris
Efficacy and Safety of Modified Nab-Paclitaxel Plus Gemcitabine Chemotherapy for Metastatic Pancreatic Cancer
Yonsei University
COTSOM
Asan Medical Center
Docetaxel 2-weeks Regimen in the Treatment of HER2 Negative Metastatic Breast Cancer
Zhejiang Cancer Hospital